Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Surekha Yadav

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Frontiers in Oncology|July 12, 2024
Comparison of <sup>18</sup>F-DCFPyL and <sup>68</sup>Ga-PSMA-11 for <sup>177</sup>Lu-PSMA-617 therapy patient selectionSurekha Yadav, Sarasa T Kim, Abuzar Moradi Tuchayi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 14, 2024
Real-World Experience with <sup>177</sup>Lu-PSMA-617 Radioligand Therapy After Food and Drug Administration ApprovalAbuzar Moradi Tuchayi, Surekha Yadav, Fei Jiang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 5, 2026
Prostate-Specific Membrane Antigen Radioligand Therapy in Patients with Aggressive-Variant Prostate CancerMoein Moradpour, Abuzar Moradi Tuchayi, Surekha Yadav, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 22, 2025
Can <sup>177</sup>Lu-DOTATATE Kidney Absorbed Doses be Predicted from Pretherapy SSTR PET? Findings from Multicenter DataAzadeh Akhavanallaf, Zhonglin Lu, Avery B Peterson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 12, 2026
PSMA PET/CT-Derived Indicators and Outcomes After [<sup>177</sup>Lu]Lu-PSMA-617: A Multicenter Retrospective Analysis from the U.S. Expanded-Access ProgramKoichiro Kimura, Vishnu Murthy, Andrew F Voter, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 2, 2024
<sup>68</sup>Ga-FAP-2286 PET of Solid Tumors: Biodistribution, Dosimetry, and Comparison with <sup>18</sup>F-FDGBrad Kline, Surekha Yadav, Youngho Seo, et al.
Radiology|April 28, 2026
<sup>177</sup>Lu-PSMA-617 SPECT/CT for Early Prediction of Overall Survival in Participants with Metastatic Castration-Resistant Prostate CancerNarjess Ayati, Nathan Papa, Megan Crumbaker, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Frontiers in Oncology|July 12, 2024
Comparison of <sup>18</sup>F-DCFPyL and <sup>68</sup>Ga-PSMA-11 for <sup>177</sup>Lu-PSMA-617 therapy patient selectionSurekha Yadav, Sarasa T Kim, Abuzar Moradi Tuchayi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 14, 2024
Real-World Experience with <sup>177</sup>Lu-PSMA-617 Radioligand Therapy After Food and Drug Administration ApprovalAbuzar Moradi Tuchayi, Surekha Yadav, Fei Jiang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 5, 2026
Prostate-Specific Membrane Antigen Radioligand Therapy in Patients with Aggressive-Variant Prostate CancerMoein Moradpour, Abuzar Moradi Tuchayi, Surekha Yadav, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 22, 2025
Can <sup>177</sup>Lu-DOTATATE Kidney Absorbed Doses be Predicted from Pretherapy SSTR PET? Findings from Multicenter DataAzadeh Akhavanallaf, Zhonglin Lu, Avery B Peterson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 12, 2026
PSMA PET/CT-Derived Indicators and Outcomes After [<sup>177</sup>Lu]Lu-PSMA-617: A Multicenter Retrospective Analysis from the U.S. Expanded-Access ProgramKoichiro Kimura, Vishnu Murthy, Andrew F Voter, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 2, 2024
<sup>68</sup>Ga-FAP-2286 PET of Solid Tumors: Biodistribution, Dosimetry, and Comparison with <sup>18</sup>F-FDGBrad Kline, Surekha Yadav, Youngho Seo, et al.
Radiology|April 28, 2026
<sup>177</sup>Lu-PSMA-617 SPECT/CT for Early Prediction of Overall Survival in Participants with Metastatic Castration-Resistant Prostate CancerNarjess Ayati, Nathan Papa, Megan Crumbaker, et al.
Pageof 3